Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
admin 4th January 2018 Uncategorised 0Big Pharma has pushed through a spate of price increases in recent weeks, and while all of them are sub-10%—the cap some companies have adopted—some of them will cost payers and consumers plenty. One of them, in fact, could be worth $1.2 billion all by itself.
More: Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Source: fierce